A retrospective analysis on the lung cancer specimens for Oncomine Dx Target Test in Keio University Hospital
Not Applicable
- Conditions
- on-small cell lung cancer (NSCLC)
- Registration Number
- JPRN-UMIN000050424
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The success rate of driver gene mutation detection in the Oncomine Dx Target Test multi-CDx system
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular targets does the Oncomine Dx Target Test identify in non-small cell lung cancer specimens at Keio University Hospital?
How does the Oncomine Dx Target Test compare to other diagnostic assays in identifying actionable mutations for NSCLC treatment?
What biomarkers are associated with response prediction to targeted therapies identified by the Oncomine Dx Test in NSCLC patients?
What are the potential adverse events associated with Oncomine Dx Target Test-guided treatment strategies in NSCLC?
What combination approaches or competitor drugs are being evaluated alongside Oncomine Dx Target Test for NSCLC at Keio University Hospital?